Patents by Inventor Steve Labudzinski
Steve Labudzinski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230278845Abstract: A lifting device, a method, and a system for lifting for utility cover is provided. The lifting device includes a body having a curved portion, the curved portion defining an interior area. A flange extends about the periphery of the body, the flange made from a compliant material that forms a seal with a top surface of an irregular or smooth surface utility cover. A lifting element is coupled and centrally positioned to the body.Type: ApplicationFiled: March 3, 2023Publication date: September 7, 2023Inventors: Richard J. Trieste, JR., Stephen Fereance, Steve Labudzinski
-
Patent number: 9278076Abstract: A chronotherapeutic pharmaceutical formulation comprising a core containing an active agent (e.g., a drug) and a surfactant and a delayed release compression coating comprising a natural or synthetic gum applied onto the surface of the core.Type: GrantFiled: March 2, 2009Date of Patent: March 8, 2016Assignee: Endo Pharmaceuticals Inc.Inventors: Anand R. Baichwal, Paul Woodcock, Steve Labudzinski
-
Publication number: 20140242166Abstract: Disclosed are sustained release oral solid dosage forms comprising a therapeutically effective amount of a medicament having a solubility of more than about 10 g/l; a pH modifying agent; and a sustained release matrix comprising a gelling agent, said gelling agent comprising a heteropolysaccharide gum and a homopolysaccharide gum capable of cross-linking said heteropolysaccharide gum when exposed to an environmental fluid, said dosage form providing a sustained release of said medicament after oral administration to human patients.Type: ApplicationFiled: March 3, 2014Publication date: August 28, 2014Applicant: Penwest Pharmaceuticals Co.Inventors: Anand R. Baichwal, Troy W McCALL, Lirong LlU, Steve LABUDZINSKI
-
Patent number: 8679535Abstract: Disclosed are sustained release oral solid dosage forms comprising a therapeutically effective amount of a medicament having a solubility of more than about 10 g/l; a pH modifying agent; and a sustained release matrix comprising a gelling agent, said gelling agent comprising a heteropolysaccharide gum and a homopolysaccharide gum capable of cross-linking said heteropolysaccharide gum when exposed to an environmental fluid, said dosage form providing a sustained release of said medicament after oral administration to human patients.Type: GrantFiled: March 27, 2007Date of Patent: March 25, 2014Assignee: Endo Pharmaceuticals Inc.Inventors: Anand R. Baichwal, Troy W. McCall, Lirong Liu, Steve Labudzinski
-
Publication number: 20090169587Abstract: A chronotherapeutic pharmaceutical formulation comprising a core containing an active agent (e.g., a drug) and a surfactant and a delayed release compression coating comprising a natural or synthetic gum applied onto the surface of the core.Type: ApplicationFiled: March 2, 2009Publication date: July 2, 2009Applicant: Penwest Pharmaceuticals Co.Inventors: Anand R. Baichwal, Paul Woodcock, Steve Labudzinski
-
Publication number: 20080085304Abstract: Robust sustained release formulations, solid dosage forms comprising robust sustained release formulations, and methods for making and using these formulations and solid dosage forms are provided. Robustness of the sustained release formulation is related to the particle size of the hydrophilic gum. Sustained release formulations resist dose-dumping when ingested with alcohol. The formulations are useful for treating a patient suffering from a condition, e.g., pain. The formulations comprise at least one drug. In one embodiment, the drug is an opioid, e.g., oxymorphone.Type: ApplicationFiled: October 10, 2006Publication date: April 10, 2008Applicant: Penwest Pharmaceuticals Co.Inventors: Anand R. Baichwal, Kevin Fitzmaurice, Steve Labudzinski
-
Publication number: 20080085303Abstract: Robust sustained release formulations, solid dosage forms comprising robust sustained release formulations, and methods for making and using these formulations and solid dosage forms are provided. Robustness of the sustained release formulation is related to the particle size of the hydrophilic gum. Sustained release formulations resist dose-dumping when ingested with alcohol. The formulations are useful for treating a patient suffering from a condition, e.g., pain. The formulations comprise at least one drug. In one embodiment, the drug is an opioid, e.g., oxymorphone.Type: ApplicationFiled: October 10, 2006Publication date: April 10, 2008Applicant: Penwest Pharmaceuticals Co.Inventors: Anand R. Baichwal, Kevin Fitzmaurice, Steve Labudzinski, Michelle Howard-Sparks, William Hein
-
Publication number: 20080085305Abstract: Robust sustained release formulations, solid dosage forms comprising robust sustained release formulations, and methods for making and using these formulations and solid dosage forms are provided. Robustness of the sustained release formulation is related to the particle size of the hydrophilic gum. Sustained release formulations resist dose-dumping when ingested with alcohol. The formulations are useful for treating a patient suffering from a condition, e.g., pain. The formulations comprise at least one drug. In one embodiment, the drug is an opioid, e.g., oxymorphone.Type: ApplicationFiled: October 10, 2006Publication date: April 10, 2008Applicant: Penwest Pharmaceuticals Co.Inventors: Anand R. Baichwal, Kevin Fitzmaurice, Steve Labudzinski, Michelle Howard-Sparks, William Hein
-
Publication number: 20070218137Abstract: Disclosed are sustained release oral solid dosage forms comprising a therapeutically effective amount of a medicament having a solubility of more than about 10 g/l; a pH modifying agent; and a sustained release matrix comprising a gelling agent, said gelling agent comprising a heteropolysaccharide gum and a homopolysaccharide gum capable of cross-linking said heteropolysaccharide gum when exposed to an environmental fluid, said dosage form providing a sustained release of said medicament after oral administration to human patients.Type: ApplicationFiled: March 27, 2007Publication date: September 20, 2007Applicant: Penwest Pharmaceuticals Co.Inventors: Anand Baichwal, Troy McCall, Lirong Liu, Steve Labudzinski
-
Publication number: 20070212414Abstract: The invention provides formulations that resist dose dumping in the presence of ethanol and methods of use thereof. The formulations can be used to prevent dose dumping, to increase safety of drugs, and to reduce abuse of drugs prone to such abuse. The formulations comprise at least one drug and a sustained release delivery system. In one embodiment, the drug is an opioid.Type: ApplicationFiled: March 8, 2006Publication date: September 13, 2007Applicant: Penwest Pharmaceuticals Co.Inventors: Anand Baichwal, Steve Labudzinski
-
Publication number: 20050118267Abstract: A chronotherapeutic pharmaceutical formulation comprising a core containing an active agent (e.g., a drug) and a surfactant and a delayed release compression coating comprising a natural or synthetic gum applied onto the surface of the core.Type: ApplicationFiled: September 17, 2004Publication date: June 2, 2005Applicant: Penwest Pharmaceuticals Co.Inventors: Anand Baichwal, Paul Woodcock, Steve Labudzinski
-
Publication number: 20040170684Abstract: Disclosed are sustained release oral solid dosage forms comprising a therapeutically effective amount of a medicament having a solubility of more than about 10 g/l; a pH modifying agent; and a sustained release matrix comprising a gelling agent, said gelling agent comprising a heteropolysaccharide gum and a homopolysaccharide gum capable of cross-linking said heteropolysaccharide gum when exposed to an environmental fluid, said dosage form providing a sustained release of said medicament after oral administration to human patients.Type: ApplicationFiled: December 18, 2003Publication date: September 2, 2004Applicant: Penwest Pharmaceuticals Co.Inventors: Anand R. Baichwal, Troy W. McCall, Lirong Liu, Steve Labudzinski